(eClinicalMedicine, 2024) in a specific study population with pre-existing reduced bone density using semaglutide 1.0 mg - not a universal finding for all GLP-1 users
23% on placebo) and 63% experienced a BMI reduction of 10% (vs
Drink more water starting the day before and continue for 48 hours after your injection
Tirzepatide SURMOUNT-1 (72 Weeks, 2,539 Participants) The SURMOUNT-1 trial was larger and longer than the Retatrutide Phase 2 study
It requires planning, communication with your healthcare provider, careful monitoring (of body weight, appetite, blood sugar, side-effects), and realistic expectations for sustained weight management
Our SGS-standardized laboratory conducts periodic testing of stored inventory using high-performance liquid chromatography, confirming that purity remains at or above ninety-eight percent throughout the storage period